Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 184877
                    [Title] => New treatment of early Parkinson’s disease cited
                    [Summary] => VIENNA, Austria – A preferable option for first-line treatment of Parkinson’s disease (PD) identified as pramipexole (Sifrol and Mirapex), was discussed by experts at the 6th Congress of the European Federation of Neurological Societies (EFNS) here.


Pramipexole (pramipexole dihydrochloride tablets), earlier approved in the United States for treating the disease in its early stages, was also recommended for the same purpose in Europe. This complies with new guidelines for managing Parkinson’s disease, issued in June 2001.


                    [DatePublished] => 2002-11-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

BOEHRINGER INGELHEIM PHARMACEUTICALS AND PHARMACIA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 184877
                    [Title] => New treatment of early Parkinson’s disease cited
                    [Summary] => VIENNA, Austria – A preferable option for first-line treatment of Parkinson’s disease (PD) identified as pramipexole (Sifrol and Mirapex), was discussed by experts at the 6th Congress of the European Federation of Neurological Societies (EFNS) here.


Pramipexole (pramipexole dihydrochloride tablets), earlier approved in the United States for treating the disease in its early stages, was also recommended for the same purpose in Europe. This complies with new guidelines for managing Parkinson’s disease, issued in June 2001.


                    [DatePublished] => 2002-11-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

New treatment of early Parkinson’s disease cited

November 21, 2002 - 12:00am

VIENNA, Austria – A preferable option for first-line treatment of Parkinson’s disease (PD) identified as pramipexole (Sifrol and Mirapex), was discussed by experts at the 6th Congress of the European Federation...

Science and Environment